OcuTerra Therapeutics
www.ocuterratx.comNon-Invasive, Transformational Approach to Treating Retinal Disease. OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity
Read more
Non-Invasive, Transformational Approach to Treating Retinal Disease. OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
1-10
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Clinical and Medical Affairs
Email ****** @****.comPhone (***) ****-****Chief Medical Officer | Executive Vice President - Clinical and Medical Affairs
Email ****** @****.comPhone (***) ****-****Director ( Chairman 2020 - 2021; Vice - Chairman 2021 - Present )
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(15)
